ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

AGIX Atherogenics (MM)

0.07
0.00 (0.00%)
After Hours
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type
Atherogenics (MM) NASDAQ:AGIX NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.07 0 01:00:00

BellwetherReport.com Analyst Opinions on SCRX, AGIX, BUCY and ISIL

02/09/2008 4:44pm

Marketwired


Atherogenics (NASDAQ:AGIX)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Atherogenics Charts.

BellwetherReport.com is the leading online financial newsletter for investors seeking top independent and unbiased research. Investors seeking free and unbiased analyst opinions on the companies mentioned in this release are encouraged to sign up to www.bellwetherreport.com for a free subscription to access these reports. Today, we have once again scheduled interviews with a number of the top analysts in North America to get an update feedback from them regarding the current market activity and position Sciele Pharma Inc. (NASDAQ: SCRX), Atherogenics Inc. (NASDAQ: AGIX), Bucyrus International Inc. (NASDAQ: BUCY) and Intersil Corporation (NASDAQ: ISIL).

To receive free access to these interviews and analyst reports sign up to www.bellwetherreport.com by clicking this link. These reports may also be updated reports so you will be able to access the past reports as on the above mentioned companies as well.

http://www.bellwetherreport.com/home/registration.php

All small-cap investors be sure to sign up to our Bellwether Report Small-Cap Newsletter.

http://www.bellwetherreport.com/home/registration.php

*Please note that analyst reports are conducted daily and immediate sign up is crucial to your success when using these reports*

All analyst reviews will be posted for free under "today's articles" within 24 to 48 hours of the interview being completed.

Each interview will vary and may include, but will not be limited to the following:

--  An Unbiased View of the Company
--  Short-term Target Prices
--  Long-term Resistance and Support Levels
--  Analyst Opinions
--  Sector Review
--  Competition Overview
--  Direct Market Integration and Influence
    

Investors looking to access these interviews are encouraged to sign up now at http://www.bellwetherreport.com/home/registration.php.

Members are also given the opportunity to receive a free "custom stock review" on any equities you currently hold in your portfolio. Simply sign up, and in the members section of www.bellwetherreport.com, you can ask an analyst for his or her opinion of any stocks you currently have in your portfolio by filling out the form under the tab "custom stock review."

Bellwether Report is not affiliated or compensated by any of the above mentioned companies, nor do we own a position in any of the companies.

Contact: Marc Johnson Managing Director Bellwether Report Email Contact

1 Year Atherogenics Chart

1 Year Atherogenics Chart

1 Month Atherogenics Chart

1 Month Atherogenics Chart

Your Recent History

Delayed Upgrade Clock